随机试验通过添加达帕格利弗洛辛来评估急性不补偿性心力衰竭的功能恶化
Shodai Kawanami1, Yasuyuki Egami1, Masaru Abe1
1Division of Cardiology, Osaka Rosai Hospital, Osaka, Japan.
ESC heart failure
|January 31, 2025
概括
将达帕格利弗洛辛添加到心力衰竭治疗中,可以减少利尿剂的需求,而不会恶化功能. 这项研究探讨了dapagliflozin.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 像达帕格利弗洛辛这样的-葡萄糖共运输体2抑制剂已被确立用于减少慢性心力衰竭中心血管死亡率.
- 急性脱补偿性心力衰竭 (ADHF) 的管理通常涉及循环利尿剂,用于液体过载.
- 达帕格利弗洛辛在ADHF期间对功能的影响需要进一步调查.
研究的目的:
- 评估添加达帕格利弗洛辛 (DAPA) 于标准脱血治疗对ADHF患者功能恶化 (WRF) 的影响.
- 为了比较ADHF患者中WRF的发病率,治疗DAPA加循环利尿剂与单独循环利尿剂.
主要方法:
- 一项前性随机试验,涉及114名ADHF患者,左心室喷射率<50%.
- 患者随机分配,在入院24小时内接受DAPA (每天10毫克) 或常规疗法 (单独循环利尿剂).
- 循环利尿剂剂量被调整以保持尿液输出;WRF被定义为与基线相比血清肌素增加≥0.3 mg/dL.
主要成果:
- 在DAPA组 (16.1%) 和常规治疗组 (12.1%) (P=0.54) 之间,WRF发生率没有显著差异.
- 与传统组相比,DAPA组在第7天需要较低的循环利尿剂总剂量 (184 ± 79.5毫克 vs. 214 ± 66.5毫克,P=0.03).
结论:
- 在ADHF患者入院后24小时内添加达帕格利弗洛辛并没有增加功能恶化的风险.
- 添加达帕格利弗洛辛导致循环利尿剂所需剂量显著降低.
- 这表明,在ADHF管理的早期可以安全地启动达帕格利弗洛辛,以优化脱.
相关概念视频
01:11Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:23Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:27Dialysis
255
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
255